Etomidate Injection — FDA Drug Shortage

Current — Mylan Institutional, A Viatris Company

The FDA lists a drug shortage record for Etomidate Injection (injection) from Mylan Institutional, A Viatris Company with status Current. The shortage was first posted on Oct 5, 2022.

Shortage details

Status
Current
Company
Mylan Institutional, A Viatris Company
Package NDC
67457-902-10
Dosage Form
Injection
Presentation
Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10)
Initial Posting
Oct 5, 2022

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.